Ursceal Pharma Private Limited
About Ursceal Pharma Private Limited
Data last updated:
Ursceal Pharma Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 24 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85110UP2019PTC117309. Its GSTIN is 09AACCU4372L1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pratap Dinesh Singh and Shipra Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 62, Noida, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹91.19 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹11.31 Lakh (net margin -12.4%) and EBITDA of -₹7.53 Lakh (EBITDA margin -8.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 23% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ursceal Pharma Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No 7 Cabin No 2 4th Floor Tower II, Plot No – C 25 Stellar IT Park Sector 62, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Ursceal Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ursceal Pharma is support service to organizations. In detail, this covers placement agencies and hr management services.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N2 | Placement agencies and HR management services |
To see the full business activity and turnover split of Ursceal Pharma Private Limited, buy the company report.
Financials of Ursceal Pharma Private Limited
FY 2025 filings availableUrsceal Pharma Private Limited reported revenue of ₹91.19 Lakh (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.3% | ||||
| Net Profit Margin | -12.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ursceal Pharma Private Limited, buy the company report.
Board of directors of Ursceal Pharma Private Limited
Ursceal Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratap Dinesh Singh | Director | 29 Nov 2023 | 2 Years 11 Months | Current |
| Shipra Srivastava | Director | 24 May 2019 | 7 Years 5 Months | Current |
| Mohit Srivastava | Director | 25 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Ursceal Pharma Private Limited is audited by RAJESH RADHEY ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH RADHEY ASSOCIATES | FY 2022 | 0500157C |
Shareholding
The shareholding of Ursceal Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ursceal Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ursceal Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ursceal Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ursceal Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCU4372L1ZW | Uttar Pradesh | Active | 03 Jun 2019 |
To see the full GST registrations and return filing status of Ursceal Pharma Private Limited, buy the company report.
Recent activity
Ursceal Pharma Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Mohit Srivastava was appointed as Director on 25 Apr 2025.
Frequently asked questions
Ursceal Pharma is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 24 May 2019 (7+ years old) and is registered under CIN U85110UP2019PTC117309.
Ursceal Pharma has 3 current directors:
- Pratap Dinesh Singh - Director
- Shipra Srivastava - Director
- Mohit Srivastava - Director
The latest financial statements of Ursceal Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Ursceal Pharma is 09AACCU4372L1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ursceal Pharma is U85110UP2019PTC117309. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ursceal Pharma was incorporated on 24 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
Mohit Srivastava was appointed as Director on 25 Apr 2025. Piush Khare ceased to be Director on 25 Apr 2025. Pratap Dinesh Singh was appointed as Director on 29 Nov 2023. Ursceal Pharma has 4 board changes on record in total.
The registered office of Ursceal Pharma is at Office No 7 Cabin No 2 4th Floor Tower II, Plot No – C 25 Stellar IT Park Sector 62, Noida, Uttar Pradesh, India – 201301.
Ursceal Pharma operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Ursceal Pharma is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
